Page 11 - Collective Coordinates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(0) TORONTO and CAMBRIDGE, Mass., May 19, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Neil Warma, MBA, to its Board of Directors with immediate effect. "I am delighted to welcome Neil Warma as a member of the ProMIS Board of Directors at this time," said Eugene Williams, Executive Chairman of ProMIS Neurosciences. "Neil's broad, internat...

ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

(0) TORONTO and CAMBRIDGE, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the appointment of Rudolph Tanzi, Ph.D, as Chair of the Company's scientific advisory board (SAB). Dr. Tanzi is the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, an...